R. Ebner, M.H. Devoto, DWeil-Treatment of thyroid associated ophthalmopathy with periocular injection of triamcinolone. BJO 2004; 88:1380-1386
R.A. Goldberg. Orbital steroid injections. BJO 2004; 88:1359-1360
Day MR, Carroll FD. Corticosteroids in the treatment of optic nerve involvement, associated with thyroid dysfunction. Arch Ophthalmol 1968; 79:279-82
Sergott RC, Glaser JS. Grave's opthalmopathy A clinical and immunologic review. Surv ophthalmol 1981;26:1-21Brown J, Coburn JW, Wigod RA et al. Adrenal steroid therapy of severe infiltrative ophthalmopathy of Grave's disease. Am J Med 1963;34:786-95
Leone CH. The management of ophthalmic Grave's disease. Ophthalmopathy 1984;91:770-9
Kazim M. Trkel S, Moore S. Treatment of acute Grave's orbitopathy. Ophthalmopathy 1991;98:1443-8
Gebertt S. Depot-methyl prednisolone for subconjunctival and retrobulbar injections. Lancet 1961;2:344-5
Garber MI. Methyl prednisolone in the treatment of exophthalmos. Lancet 1966;1:958-60
Trobe JD, Glaser JS Laflamme P. Dysthyroid optic neuropathy. Clinical profile and rationle of management. Arch ophthalmol 1978;96:1199-209
Teus MA, Teruel JL, Pascual J, et al. Corticosteroid induced toxic neuropathy. Am J Ophthalmol 1991;112:605-6
Egbert JE, Schwartz S Walsh AW. Diagnosis and treatment of an ophthalmic artery occlusion during an intralesional injection of corticosteroid into an eyelid capillary hemangioma. Am J ophthlmol 1996; 121:638-42
Koornif L. New insights in the human orbital connective tissue. Arch Ophthalmol 1977;95: 1269-73
Fraunfelder FT, Grsove JA. In: Drug induced ocular side effects,4th ed. Baltimore: Williams & Wilkins, 1996:323-8
Bhisitkul RB, Lee OT, Wong J, Pereira DD, Porco TC. neuroprotective effect of triamcinolone acetonide against photoreceptor apoptosis in a rabbit model of subretinal haemorrhage. Invest Ophthalmol Vis Sci.2008 April 17.
Brain R. Cortisone in exophtalmos, report on a therapeutic trial of cortisone and corticotrophin (ACTH) in exophthalmos and exophthalmic ophthalmoplegia by a panel appointed by the Medical Research Council. Lancet 1955;1:6-9.
Brown J, Coburn JW, Wigod RA, et al. Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves' disease. Am J Med 1963;34:786-95.
Werner SC. Prednisone in emergency treatment of malignant exophthalmos. Lancet 1966;1:1004-7.
Day MR, Carroll FD. Corticosteroids in the tratment of optic nerve involvement, associated with thyroid dysfunction. Arch Ophthalmol 1968; 79:279-82.
Fiebel RM, Roper-Hall G. Evaluation of the field of binocular single vision in incomitant strabismus. Am J Ophthalmol 1974; 78:800-5.
Apers RCL, Oosterhuis JA, Goslings BM, et al. Prednisone treatment in endocrine opthalmopathy. Mod Probl Ophthalmol 1975; 14:414-2022 Jacobson DH, Gorman CA. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and treatment. Endocr Rev 1984;5:200-20.
McConahey WM. Medical therapy. In: Gorman CA, Waller RR, Dyer JA, eds. In: The eye and orbit in thyroid disease. New York: Raven Press, 1984:317-24.
Nagayama Y, Izumi M, Kiriyama T, et al. Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisone pulse therapy. Acta Endocrinol 1987;116:513-18.
Kendall-Taylor P, Combie AL, Stephenson AM, et al. Intraveous methylprednisone in the tratment of Graves' opthalmopathy. BMJ 1988; 297:1547-78.
Bartalena L, Marcocci C, Bogazzi F, et al. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism. N Engl J Med 1989; 321:1349-52.
Hiromatsu Y, Tanaka K, Sato M, et al. Intravenous methylprednisone pulse therapy for Graves' ophthalmopathy. Endocr J 1993; 40:63-72. 28 Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995; 273:808- 12. 29 Della Casa F. Zur Therapie des malignen Exophthlmus. Ophthalmologica 1970;161:145-51.
Cant JS. The assessment and treatment of endocrine exophthalmos. Proc Roy Soc Med 1970;63:783-6.
Ivy HK. Medical aproach to ophthalmopathy of Graves' disease. Mayo Clin Proc 1972;47:980-5.
Thomas ID, Hart JK. Retrobulbar repository corticosteroid therapy in thyroid ophthalmopathy. Med J Aust 1974; 2:484-7.
Kramar P. Manegement of eye changes of Graves' disease. Surv Ophthalmol 1974; 18:369-82.
Marcocci C, Bartalena L, Panicucci M, et al. Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study. Clin Endocrinol 1987; 27:33-42.
Huber A. Ocular motility in Graves' disease. Neuroophthalmology 1984; 4:227-36.
Feibel RM, Roper-Hall G. Evaluation of the field of binocular single vision in incomitant strabismus. Am J Ophthalmol 1974;78:800-5. 39 Jordan DC, Flood JG, Lapostata M, et al. Normal reference laboratory values. N Eng J Med 1992; 327:718-24.
Goodman AG, Gilman LS. Adrenocortical steroids and their synthetic analogs. In: The pharmacological basis of therapeutics. 9th ed. Chapter 59. New York: McGraw-Hill, 1996:1465-76.
Koorneef L. Orbital septa: anatomy and function. Ophthalmology 1979;86:876-80.
Wearne MJ, Flaxel C h J, Gray P, et al. Vitreoretinal surgery after inadvertent globe penetration during local ocular anesthesia. Ophthalmology 1998;105:371-644
Gomez-Ulla F, Gonzales F, y Ruiz-Fraga C, Unintentional intraocular injection of corticosteroids. Acta Ophthalmol 1993;71:419- 21.
Bullock JD, Warwar RE, Green R. Ocular explosions from periocular anesthetic injections. Ophthalmology 1999; 106:2341-53.
Lam DSCS, Law RWK, Leung ATS, et al. Intraorbital needle fragment: a rare complication of retrobulbar injection. Arch Ophthalmol 1999; 117:1089-90.
Droste PJ, Ellis FD, Sondhi N, et al. Linear subcutaneous fat atrophy after corticosteroid injection of periocular hemangiomas. Am J Ophthalmol 1988; 105:65-9.
